Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults-Reference-Cited by-同舟云学术

Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults

Published:2022-11 Issue:11 Volume:22 Page:1596-1605
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

van der Boor Saskia C,Smit Merel J,van Beek Stijn W,Ramjith Jordache,Teelen Karina,van de Vegte-Bolmer Marga,van Gemert Geert-Jan,Pickkers Peter,Wu Yimin,Locke Emily,Lee Shwu-Maan,Aponte John,King C Richter,Birkett Ashley J,Miura Kazutoyo,Ayorinde Morolayo A,Sauerwein Robert W,ter Heine Rob,Ockenhouse Christian F,Bousema Teun,Jore Matthijs M,McCall Matthew B B

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference28 articles.

1. World malaria report 2021,2021

2. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda;Uwimana;Nat Med,2020

3. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015;Bhatt;Nature,2015

4. A monoclonal antibody for malaria prevention;Gaudinski;N Engl J Med,2021

5. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants;Pediatrics,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype;Cell;2024-09

2. Multistage protective anti-CelTOS monoclonal antibodies with cross-species sterile protection against malaria;Nature Communications;2024-08-29

3. Malaria vaccines: a new era of prevention and control;Nature Reviews Microbiology;2024-07-18

4. Vaccines and monoclonal antibodies: new tools for malaria control;Clinical Microbiology Reviews;2024-06-13

5. A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial;BMC Medicine;2024-04-23